These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6744637)

  • 21. Proinsulin and C-peptide: a review.
    Kitabchi AE
    Metabolism; 1977 May; 26(5):547-87. PubMed ID: 403392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of proinsulin in human pancreatic juice.
    Murozono S; Sato K; Picazo J; Ishii H
    Horm Metab Res; 1989 Nov; 21(11):619-22. PubMed ID: 2687146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoradiometric assay of human proinsulin and partially processed proinsulin with use of monoclonal antibody and streptavidin-biotin labeling.
    Kim JQ; Cho HI; Kim SI; Lee HK; Hales CN
    J Korean Med Sci; 1989 Dec; 4(4):171-7. PubMed ID: 2639693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoradiometric assay of human intact proinsulin applied to patients with type 2 diabetes, impaired glucose tolerance, and hyperandrogenism.
    Chevenne D; Ruiz J; Lohmann L; Laudat A; Leblanc H; Gray IP; Passa P; Porquet D
    Clin Chem; 1994 May; 40(5):754-7. PubMed ID: 8174247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rapid and sensitive radioimmunoassay for the measurement of proinsulin in human serum.
    Bowsher RR; Wolny JD; Frank BH
    Diabetes; 1992 Sep; 41(9):1084-90. PubMed ID: 1499862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.
    Kahn SE; Halban PA
    Diabetes; 1997 Nov; 46(11):1725-32. PubMed ID: 9356018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proinsulin: biosynthesis, conversion, assay methods and clinical studies.
    Csorba TR
    Clin Biochem; 1991 Dec; 24(6):447-54. PubMed ID: 1773484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical and clinical implications of proinsulin conversion intermediates.
    Given BD; Cohen RM; Shoelson SE; Frank BH; Rubenstein AH; Tager HS
    J Clin Invest; 1985 Oct; 76(4):1398-405. PubMed ID: 3902891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial hyperproinsulinemia. Two cohorts secreting indistinguishable type II intermediates of proinsulin conversion.
    Robbins DC; Shoelson SE; Rubenstein AH; Tager HS
    J Clin Invest; 1984 Mar; 73(3):714-9. PubMed ID: 6368587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proinsulin and C-peptide in diabetes.
    Horwitz DL; Rubenstein AH; Steiner DF
    Med Clin North Am; 1978 Jul; 62(4):723-33. PubMed ID: 98676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevation of C-peptide immunoreactivity in plasma of normal subjects after trypsin action.
    Beck B; Villaume C; Debry G
    Diabete Metab; 1980 Mar; 6(1):25-9. PubMed ID: 6989659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A method for determination of proinsulin levels in serum using both insolubilized anti-insulin antibody and anti-C-peptide antibody].
    Sasakuma F; Hasegawa K; Ishikawa O; Matumiya K; Yagi K; Kitamura H; Kojima J
    Rinsho Byori; 1992 Jul; 40(7):769-74. PubMed ID: 1507496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Characterization and application of monoclonal antibodies to proinsulin, insulin and C-peptide].
    Wu CY
    Zhonghua Yi Xue Za Zhi; 1988 Oct; 68(10):557-60, 38. PubMed ID: 3242748
    [No Abstract]   [Full Text] [Related]  

  • 34. Time-Resolved Fluorescence Assays for Quantification of Insulin Precursors in Plasma and Serum.
    Taylor K; Halsall I; Guest PC; Burling K
    Methods Mol Biol; 2018; 1735():457-465. PubMed ID: 29380336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a synthetic peptide antigen to generate antisera reactive with a proteolytic processing site in native human proinsulin: demonstration of cleavage within clathrin-coated (pro)secretory vesicles.
    Steiner DF; Michael J; Houghten R; Mathieu M; Gardner PR; Ravazzola M; Orci L
    Proc Natl Acad Sci U S A; 1987 Sep; 84(17):6184-8. PubMed ID: 3306670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly specific radioimmunoassay for human insulin based on immune exclusion of all insulin precursors.
    Deberg M; Houssa P; Frank BH; Sodoyez-Goffaux F; Sodoyez JC
    Clin Chem; 1998 Jul; 44(7):1504-13. PubMed ID: 9665430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degradation of proinsulin and isolated C-peptide by rat kidney neutral metallo-endopeptidase.
    Varandani PT; Shroyer LA
    Biochim Biophys Acta; 1981 Oct; 661(2):182-90. PubMed ID: 7028123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The production and characterization of monoclonal antibodies specific for human proinsulin using a sensitive microdot assay procedure.
    Madsen OD; Cohen RM; Fitch FW; Rubenstein AH; Steiner DF
    Endocrinology; 1983 Dec; 113(6):2135-44. PubMed ID: 6196183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ELISA for human proinsulin.
    Hartling SG; Dinesen B; Kappelgård AM; Faber OK; Binder C
    Clin Chim Acta; 1986 May; 156(3):289-97. PubMed ID: 3719986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin.
    Gruppuso PA; Gorden P; Kahn CR; Cornblath M; Zeller WP; Schwartz R
    N Engl J Med; 1984 Sep; 311(10):629-34. PubMed ID: 6382002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.